Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
The Oncologist
|
December 30, 2025
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer
Albert Jang, Peggy Fowler, Kathryn Helminiak, et al.
European Urology Oncology
|
December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Tanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
The Oncologist
|
June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens
Jeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
JCO Precision Oncology
|
April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations
Joseph J Park, Alec Chu, Jinju Li, et al.
Nature Communications
|
December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
Soumyajit Roy, Yilun Sun, Maha Hussain, et al.
Cancer
|
December 9, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Vadim S Koshkin, Nicholas Henderson, Marihella James, et al.
The Oncologist
|
October 7, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, et al.
JAMA Network Open
|
January 16, 2026
Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, June K Corrigan, Jennifer La, et al.
Clinical Genitourinary Cancer
|
February 5, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Albert Jang, Tanya Jindal, Ali Raza Khaki, et al.
The Oncologist
|
August 13, 2022
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization
Andrew G Shuman, Matti S Aapro, Benjamin Anderson, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
The Oncologist
|
December 30, 2025
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer
Albert Jang, Peggy Fowler, Kathryn Helminiak, et al.
European Urology Oncology
|
December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Tanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
The Oncologist
|
June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens
Jeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
JCO Precision Oncology
|
April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations
Joseph J Park, Alec Chu, Jinju Li, et al.
Nature Communications
|
December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
Soumyajit Roy, Yilun Sun, Maha Hussain, et al.
Cancer
|
December 9, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Vadim S Koshkin, Nicholas Henderson, Marihella James, et al.
The Oncologist
|
October 7, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, et al.
JAMA Network Open
|
January 16, 2026
Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, June K Corrigan, Jennifer La, et al.
Clinical Genitourinary Cancer
|
February 5, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Albert Jang, Tanya Jindal, Ali Raza Khaki, et al.
The Oncologist
|
August 13, 2022
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization
Andrew G Shuman, Matti S Aapro, Benjamin Anderson, et al.
Page
of 21